Christine Carrington

ORCID: 0000-0002-7372-1154
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices
  • Medication Adherence and Compliance
  • Cancer Treatment and Pharmacology
  • Economic and Financial Impacts of Cancer
  • Patient Safety and Medication Errors
  • Clinical practice guidelines implementation
  • Safe Handling of Antineoplastic Drugs
  • Lymphoma Diagnosis and Treatment
  • Telemedicine and Telehealth Implementation
  • Cancer survivorship and care
  • Chemotherapy-related skin toxicity
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Lymphocytic Leukemia Research
  • Healthcare Systems and Technology
  • Health Systems, Economic Evaluations, Quality of Life
  • Palliative Care and End-of-Life Issues
  • Healthcare Quality and Management
  • Global Cancer Incidence and Screening
  • Pharmacy and Medical Practices
  • Quality and Safety in Healthcare
  • Mobile Health and mHealth Applications
  • Lung Cancer Treatments and Mutations
  • Muscle and Compartmental Disorders
  • Cancer Risks and Factors

The University of Queensland
2020-2025

Princess Alexandra Hospital
2008-2024

Princess Alexandra Hospital
2007-2021

Metro South Health
2020

Arena Pharmaceuticals (United States)
2020

University Hospital of Wales
2014

Cancer Services
2005-2013

Women's Hospital
2013

Queensland Health
2010

Mater Health Services
2005-2006

Abstract The issue of medication safety is highly significant when anti‐cancer therapy used as a treatment modality due to the high potential for harm from these agents and disease context in which they are being used. These guidelines provide recommendations on safe prescribing, dispensing administration chemotherapy related cancer. represent multidisciplinary collaboration standardise complex process providing cancer enhance patient safety. consensus based best available evidence expert...

10.1111/j.1743-7563.2010.01321.x article EN Asia-Pacific Journal of Clinical Oncology 2010-08-31

Background: Health practitioners should possess relevant, up to date skills and be able perform within their required scope of practice ensure that they are competent. Maintaining the competency health care professionals is a key principle clinical governance risk management. The aim this project was develop framework for pharmacists providing pharmaceutical cancer patients. Methodology: An initial draft developed based on existing documentation adapted needs Queensland (QH) facilities....

10.1177/1078155210365582 article EN Journal of Oncology Pharmacy Practice 2010-04-15

Study objective. The aim of this retrospective study was to determine the incidence vinca alkaloid extravasation following administration via syringes or mini-bags. Methods. An electronic survey sent pharmacy departments at hospitals throughout Australia. designed collect data on methods alkaloids (vincristine, vinblastine, vinorelbine) and corresponding documented extravasation. questionnaire requested information: how drugs were prepared for (syringe mini-bag); volume each product; number...

10.1177/1078155206070448 article EN Journal of Oncology Pharmacy Practice 2006-06-01

10.5694/j.1326-5377.2004.tb06394.x article EN The Medical Journal of Australia 2004-10-01

Abstract Background Due to advances in early detection and cancer treatment, 5-year relative survival rates for breast surpass 90% developed nations. There is increasing focus on promotion of wellness survivorship active approaches reducing morbidity related treatment; however, current models follow-up care are heavily reliant hospital-based specialist-led care. This study aims test the feasibility EMINENT intervention implementing an integrated, shared-care model involving both centre...

10.1186/s13063-020-04740-1 article EN cc-by Trials 2020-10-15

The issue of medication safety is highly significant when anti-cancer therapy used due to the high potential for harm from these agents and disease context in which they are being used. This article reports on development multidisciplinary consensus guidelines safe prescribing, dispensing administration cancer chemotherapy undertaken by a working group Clinical Oncological Society Australia (COSA).A pharmacists, nurses medical oncologists was convened COSA membership. A draft set proposed...

10.1111/j.1743-7563.2010.01313.x article EN Asia-Pacific Journal of Clinical Oncology 2010-08-31

All health professionals involved should:• have appropriate training and skills in the use of cytotoxic chemotherapy cancer care, when therapy is being used this context 7• seek advice from a practitioner experienced required

10.18773/austprescr.2013.006 article EN cc-by-nc-nd Australian Prescriber 2013-02-01

The primary aim was to compare the successful completion rates of pre-treatment medication history consults conducted by pharmacists with patients either via an unscheduled telephone consult (current standard care) or a scheduled videoconference model. Secondary aims were examine pharmacist perceptions and explore patient (+/- support person) consults.Completion data collected compared for two modalities. In addition, commented on any positive/negative factors impacting all consults. For...

10.1177/1357633x221122140 article EN Journal of Telemedicine and Telecare 2022-11-08

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by authors. Any queries (other than missing content) should be directed to corresponding author article.

10.1038/clpt.2014.3 article EN Clinical Pharmacology & Therapeutics 2014-03-20

ABSTRACT Although most cancer medicines are administered parenterally, there has been an increase in the availability of oral antineoplastics. Oral antineoplastics offer several advantages, including ease administration, convenience and cost savings. Disadvantages may include reduced patient supervision, concordance issues, inappropriate selection unpredictable bioavailability. A number safety storage prevention medication errors, must also be addressed. Safe handling techniques optimised to...

10.1002/j.2055-2335.2005.tb00337.x article EN Journal of Pharmacy Practice and Research 2005-09-01

Abstract The aim of this brief report was to retrospectively compare the severity and incidence hypersensitivity reactions (HSRs) in patients who received ranitidine did not receive ranitidine, as part their pre‐medication prior paclitaxel. Data collected for receiving paclitaxel‐containing protocols breast, head neck, or lung cancers 2019 2020. data included pre‐medications administered each paclitaxel dose, total doses whether a HSR event occurred along with its severity. Eighty were...

10.1002/jppr.1768 article EN Journal of Pharmacy Practice and Research 2022-02-01

Introduction: This study examined the reimbursement opportunity and time efficiency of a standard care model unscheduled telephone consults compared to scheduled videoconference for obtaining pre-treatment medication histories patients with cancer. Methods: Data related (a) available claimed activity-based funding both models (b) number contacts duration each contact complete patient's history via either or were collected compared. Results: was 86 56 consults. The actual $0, even though $86...

10.1177/1357633x211048393 article EN Journal of Telemedicine and Telecare 2021-11-02

Abstract Aim Nonadherence to oral chemotherapy (OC) can lead health complications, including premature death. Mobile phones are increasingly used deliver medication adherence interventions. However, there is limited evidence about mobile phone–based interventions increase OC, specifically. This study explores the proof‐of‐concept of a smartphone program support OC in people with cancer. Methods was 10‐week, nonrandomized, multisite trial. The outcomes assessed were acceptability,...

10.1111/ajco.13656 article EN Asia-Pacific Journal of Clinical Oncology 2022-01-30

Abstract Aim: Etoposide is used in a wide variety of solid and hematological tumors. It available Australia two intravenous formulations; etoposide base the phosphate salt with 113.6 mg being equivalent to 100 base. Variances between dose prescribed that actually given have been reported recently patients receiving either too much or little intended etoposide. We carried out review national practices prescribing, dispensing labeling phosphate. Methods: Cancer care clinicians pharmacists,...

10.1111/j.1743-7563.2010.01317.x article EN Asia-Pacific Journal of Clinical Oncology 2010-07-23
Coming Soon ...